FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online August 1, 2003 as doi:10.1096/fj.03-0082fje.
Published as doi: 10.1096/fj.03-0082fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/13/1901
03-0082fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NICOU, A.
Right arrow Articles by TORDJMANN, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NICOU, A.
Right arrow Articles by TORDJMANN, T.
(The FASEB Journal. 2003;17:1901-1903.)
© 2003 FASEB

Hypothalamic vasopressin release and hepatocyte Ca2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow1

ALEXANDRA NICOU*,2, VALÉRIE SERRIÈRE*,2, SYLVIE PRIGENT*, SYLVIANE BOUCHERIE*, LAURENT COMBETTES*, GILLES GUILLON{dagger}, GÉRARD ALONSO{ddagger} and THIERRY TORDJMANN*,3

* Unité de Recherche U.442, Institut National de la Santé et de la Recherche Médicale, Université Paris Sud, 91405 Orsay, France; and
{dagger} Unité de Recherche U.469, Institut National de la Santé et de la Recherche Médicale and
{ddagger} UMR5101 Centre National de la Recherche Scientifique, 34094 Montpellier, France

3Correspondence: Unité de Recherche U.442, Institut National de la Santé et de la Recherche Médicale, Université Paris Sud, bât. 443, 91405 Orsay, France. E-mail: thierry.tordjmann{at}ibaic.u-psud.fr

SPECIFIC AIMS

After partial hepatectomy, liver mass is restored through a complex regulatory network of cytokines, growth factors, and hormones. In this study, we show that an interplay between hypothalamic vasopressin secretion and a remodeling of Ca2+ signals in the liver contributes significantly to rat liver compensatory growth and bile flow.

PRINCIPAL FINDINGS

1. Plasma arginine vasopressin (AVP) concentration highly increases through an activation of hypothalamic nuclei early after partial hepatectomy
Plasma AVP concentration increased sharply after partial hepatectomy, peaking 1 h after surgery (1.0±0.5 pg/mL, n=10 before surgery vs. 21.6±1.6 pg/mL, n=5 afterward), and remained higher than in the sham group for the following 24 h. A significant but smaller increase in AVP concentration was observed 1 h after sham operation (6.9±1.9 pg/mL, n=5).

We found that hypothalamic neurons of supraoptic (SON) and paraventricular (PVN) nuclei are stimulated after hepatectomy (and not sham surgery), using an antibody directed against the proto-oncogene c-fos protein product c-Fos, a well-established activation marker for neurons in response to a variety of stimuli. Only faint c-Fos immunostaining could be detected in the forebrains of sham-operated rats 1 h (Fig. 1 A, n=4) and 24 h (not shown) after surgery. In contrast, 1 h after hepatectomy, strong c-Fos immunostaining was associated with the nucleus of numerous neuron-like cells located within the SON (Fig. 1B , n=4) and PVN (not shown). This labeling was also observed 2 h after hepatectomy but was absent 24 h later (data not shown). Examination of triple immunostained hypothalamus sections 1 h after hepatectomy indicated that most of the c-Fos-positive neurons located within the SON (and the PVN, not shown) were immunostained for AVP or ocytocin (OT) (Fig. 1C ). These data strongly support the idea that the increase in circulating AVP detected 1 h after hepatectomy originated in the hypothalamic AVP neurons. The amount of hypothalamic AVP mRNA, analyzed by semiquantitative RT-PCR, increased by 60% in the 8th hour after hepatectomy before returning to the basal level between the second and the third day (Fig. 1D ), suggesting that further AVP is synthesized to replenish neuronal stores, as previously reported after osmotic or hemorrhagic stress.



View larger version (43K):
[in this window]
[in a new window]
 
Figure 1. Hypothalamic AVP-secreting neurons are activated after partial hepatectomy. A, B) Single c-Fos immunostaining. A) 1 h after sham surgery, c-Fos immunostaining was undetectable throughout the supraoptic nucleus (SON). B) 1 h after hepatectomy, intense c-Fos immunostaining was associated with numerous cell nuclei located within the SON. C) Confocal images of a section triple immunostained for OT, AVP, and c-Fos. Throughout the SON, c-Fos immunostaining (green) was essentially associated with the nucleus of neurons immunostained for AVP (red) or OT (blue). Representative photomicrographs of four experiments. OC: optic chiasma. The hatched line in panel A delimits the anatomical extent of the SON. Scale bars = 100 µm. D) Time course of hypothalamic AVP mRNA amount after partial hepatectomy. Photographs representative of 4 experiments and semiquantitative analysis of RT-PCR gels are shown. At each time point, the abundance AVP mRNA was compared (in %) in sham-operated and hepatectomized rats. Relative levels of AVP mRNA were analyzed by scanning densitometry. For each sample, the density of the AVP mRNA band was normalized to the ß-actin band. Each data point is the mean ± SE of 4–6 independent experiments. *P <0.05, **P <0.001 compared with sham values.

2. Remodeling of AVP-induced Ca2+ signaling and V1a receptor expression after partial hepatectomy
We explored the responsiveness of hepatocytes to AVP by measuring the capacity of cells to mobilize intracellular Ca2+ in response to the hormone. Hepatocytes remained fully responsive to AVP (and to other Ca2+-mobilizing agonists) during the first 8 to 10 h and began to exhibit a lower sensitivity to AVP 12 h after hepatectomy. Then, two phases of deep hepatocyte desensitization occurred (at 20–24 h and 96–120 h). Almost basal cell sensitivity to hormones recovered ~6 days after hepatectomy. AVP-triggered [Ca2+]i responses exhibited significantly longer latencies in regenerating hepatocytes at 24 h (37±5 s vs. 19±4 s, P<0.05, n=5). Furthermore, a greater proportion of regenerating hepatocytes (57.5±3.5% vs. 23±7%, P<0.01, n=5) exhibited oscillating responses. Given that different sets of genes can be switched on or off by different [Ca2+]i kinetic patterns, hepatocyte Ca2+ signaling adaptation during liver regeneration may tune gene expression to leave the G0 quiescent state.

Remodeling of hormone receptor density and lobular distribution were found during liver regeneration. Autoradiographs ([125I]HO-LVA) of liver sections from sham-operated and hepatectomized rats showed that regenerating livers contained 2.48 ± 0.3-fold (P<0.001, n=5) less V1a binding sites than sham livers 24 h after surgery. The amount of V1a mRNA analyzed with RT-PCR was lower in hepatectomized rats than in sham-operated rats 8 and 12 h after surgery (36.9±4.6 and 48.7±6% of sham values, respectively; P<0.001, n=3) and was similar in both rat groups at 24 h, remaining stable thereafter. These kinetics suggest that the observed drop in V1a density 24 h after hepatectomy is at least partly due to transcriptional regulation. The V1a receptor distribution was highly heterogeneous, perivenous (PV) areas being richer in this receptor than periportal (PP) regions, as reported in control non-operated rats. At 24 h, the PV/PP gradient in V1a density was significantly (P<0.001) higher (3.16±0.13, n=5) in hepatectomized rats than in sham-operated rats (2.18±0.09, n=5) because of a more pronounced loss of V1a receptors in the PP than in the PV area.

3. AVP contributes to liver growth after partial hepatectomy
The specific V1a receptor antagonist SR49059 was used to study the in vivo effect of AVP in the rat after hepatectomy. V1a antagonism strongly reduced liver mass restoration, mainly in the first 24 (P<0.001, n=6) to 48 (P=0.05, n=6) h after partial hepatectomy (Fig. 2 A). The liver mass was subsequently restored similarly in control and SR49059-treated rats. The peak DNA synthesis 24 h after partial hepatectomy was also significantly damped in SR49059-treated rats compared with controls, as measured by the percentage of hepatocytes incorporating BrdU (P=0.001, n=4) (Fig. 2B ) and by assessing thymidine kinase activity (P=0.05, n=4) (Fig. 2C ). Thus, AVP may help quiescent G0 hepatocytes to enter the cell cycle in G1 and to progress to the S phase, thus restoring liver mass. In line with these results, significantly lower amounts of cyclin D1 and cyclin A proteins were detected in treated vs. untreated rats 24 and 48 h (P<0.05, n=4) after hepatectomy. Also, NF-{kappa}B, a crucial transcription factor implicated in the priming of hepatocytes leading to immediate early gene expression, was significantly less activated in rats treated with the V1a antagonist than in vehicle-treated rats, mainly at 30 min (P<0.01, n=4) after partial hepatectomy. Given that NF-{kappa}B is submitted to Ca2+-dependent regulation, it is tempting to suggest that AVP-elicited [Ca2+]i oscillations in hepatocytes contribute to the activation of this transcription factor.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 2. AVP contributes to liver growth after partial hepatectomy. Rats were treated with SR49059 (SR) or its vehicle (GA) before hepatectomy. A) Liver weight increase. The weight of the resected lobes (representing 70% of the entire liver was used to calculate the preoperative liver weight. The liver weight (l.w.) recovery was calculated (in %) at different time points after hepatectomy, by comparison between the liver remnant weight estimated at time of operation ("l.w. at HX") and liver remnant weight measured at the time of death. B) BrdU incorporation. At each time point, hepatocytes isolated 2 h after intraperitoneal BrdU injection were processed for BrdU immunodetection. C) Thymidine kinase activity determined on frozen livers at the times indicated, after surgery. In sham-operated rats, BrdU incorporation was observed in 0.2% of hepatocytes (n=4) and thymidine kinase activity was 14.2 ± 5.5 pmol·min-1·mg prot-1 (n=3).

4. AVP contributes to bile flow after partial hepatectomy
AVP is a regulator of bile flow in the rat due to its capacity to generate intercellular calcium waves, which are spatially oriented along the acinus axis by a V1a receptor gradient. Given that soon after hepatectomy and later, the AVP concentration is high in the plasma and that the V1a receptor gradient is enhanced in the liver lobule, we examined the regulation of bile flow by AVP (10–300 pM) in the regenerating liver. We calculated that the choleretic effect of AVP was significantly enhanced (P<0.001, n=5) and the cholestatic effect was largely dampened (P<0.001, n=5) in hepatectomized rats at 24 h compared with sham-operated rats. These results suggest that AVP is an in vivo regulator of bile flow when the functional mass of hepatocytes is reduced. Based on our previous work, the observed amplification of the V1a receptor lobular gradient may account for the enhanced impact of AVP on bile flow during liver regeneration. Further studies are required to determine the consequences of a steeper V1a receptor density gradient along hepatocyte plates on intercellular Ca2+ wave kinetics during liver regeneration.

CONCLUSIONS AND SIGNIFICANCE

In conclusion, our study provides new insights into the physiological impact of AVP on liver function (Fig. 3 ). A very early hypothalamic release of AVP after partial hepatectomy helps the liver to initiate its mass recovery. On the other hand, AVP appears to stimulate bile flow during liver regeneration. The remodeling of hepatocyte AVP-induced Ca2+ signaling after partial hepatectomy is suggested to underlie these effects, a lower number of V1a receptors together with a steeper lobular receptor gradient appearing to promote AVP efficiency during liver regeneration.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. A very early stimulation of hypothalamic AVP-secreting neurons occurs after partial hepatectomy, through a yet unknown pathway. The resulting release of AVP in the blood helps the liver to initiate its mass recovery and stimulates bile flow during liver regeneration. The remodeling of hepatocyte AVP-induced Ca2+ signaling after partial hepatectomy is suggested to underlie these effects. The role of AVP in this remodeling is not known.

FOOTNOTES

1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.03-0082fje; doi: 10.1096/fj.03-0082fje

2 A.N. and V.S. contributed equally to this work.




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Bailly-Maitre, E. Bard-Chapeau, F. Luciano, N. Droin, J.-M. Bruey, B. Faustin, C. Kress, J. M. Zapata, and J. C. Reed
Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration
Cancer Res., February 15, 2007; 67(4): 1442 - 1450.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. O'Brien, D. A. Gomes, S. Sehgal, and M. H. Nathanson
Hormonal Regulation of Nuclear Permeability
J. Biol. Chem., February 9, 2007; 282(6): 4210 - 4217.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Hiroyama, T. Aoyagi, Y. Fujiwara, J. Birumachi, Y. Shigematsu, K. Kiwaki, R. Tasaki, F. Endo, and A. Tanoue
Hypermetabolism of Fat in V1a Vasopressin Receptor Knockout Mice
Mol. Endocrinol., January 1, 2007; 21(1): 247 - 258.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/13/1901
03-0082fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NICOU, A.
Right arrow Articles by TORDJMANN, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NICOU, A.
Right arrow Articles by TORDJMANN, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS